JPRN-UMIN000013263已完成未知
A phase 2 study of Neoadjuvant chemotherapy in Docetaxel plus Cyclophosphamide plus Trastuzumab with Operable HER2 Positive breast cancer - A phase 2 study of Neoadjuvant chemotherapy in Docetaxel plus Cyclophosphamide plus Trastuzumab with Operable HER2 Positive breast cancer
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 70years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1)Poorly controlled complication (malignant hypertension, myocardial infarction , congestive heart failure, bleeding). 2)Multiple primary cancer 3)Synchronous bilateral breast cancer 4)Interstitial pneumonia and pulmonary fibrosis diagnosed by chest X-rays or CT scan. 5)Women who are pregnant, lactating or with childbearing potential 6)Hypersensitivity to any agents necessary in the planned treatment. 7)Serious peripheral neuropathy or serious edema 8)Pleural effusion or cardiac effusion which requires treatment 9)Complication which requires prior treatment with corticosteroid 10)Suspected infection 11)Ineligible based on decision of an investigator
研究者
相似试验
已完成
2 期
Pase II study of neoadjuvant chemotherapy with Docetaxel, Carboplatin, and Trastuzumab for operable Her2-positive breast cancer patients.Her2-positive breast cancerJPRN-UMIN000012256Kyushu Breast Cancer Study Group30
已完成
2 期
A Phase II study of Neoadjuvant chemotherapy in Docetaxel and Cyclophosphamide(TC therapy) with Operable HER2 Negative breast cancerbreast cancerJPRN-UMIN000013261Kyoto Prefectural University of Medicine50
已完成
不适用
PhaseII study of neoadjuvant chemotherapy with the nab Paclitaxel And Trastuzumab followed by FEC for the HER2-positive resectable primary breast cancerHER2 positive resectable primary breast cancerJPRN-UMIN000008465Osaka Breast Cancer Chemo-Endocrine Therapy Study Group30
招募中
不适用
A phase II study of Neoadjuvant chemotherapy plus Durvalumab (MEDI4736) and Tremelimumab in Advanced-stage ovarian cancer (TRU-D)NeoplasmsKCT0003742Yonsei University Health System, Severance Hospital24
进行中（未招募）
1 期
Phase II Study of Neoadjuvant Chemotherapy With Dose-Dense Paclitaxel In Association With Carboplatin followed by Radical Surgery for Locally Advanced Cervical Cancer (FIGO stage IB2- IIIA) Patients.EUCTR2016-003294-18-ITFONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI46